Literature DB >> 7675124

Low concentrations of UD-CG 212 enhance myocyte contractility by an increase in calcium responsiveness in the presence of inorganic phosphate.

J C van Meel1, N Redemann, W Diederen, R M Haigh.   

Abstract

Recent data show that UD-CG 212 in nanomolar concentrations increases myofibrillar Ca++ responsiveness of chemically skinned cardiac preparations in the presence of elevated inorganic phosphate. We studied the effects of UD-CG 212 on cell shortening of intact myocytes and in addition measured the intracellular calcium transients with the aid of INDO-1 fluorescence in the presence of 5 mM inorganic phosphate. The validity of our experimental system was first tested with the calcium channel opener Bay k 8644. Bay k 8644 at 10(-8) M did not significantly influence myocyte shortening (+ 13.9 +/- 4.6%, n = 9) but at 10(-7) M and 10(-6) M significantly increased contraction by 40.1 +/- 13.6% and 52.5 +/- 17.0% respectively. Bay k 8644 at 10(-8) M increased the INDO-1 fluorescence ratio by 17.3 +/- 4.7% (P < 0.01; n = 9), and at 10(-7) M by 21.5 +/- 4.3% (P < 0.01; n = 9), whereas 10(-6) M Bay k 8644 had no significant effect on peak INDO-1 ratio. However, 10(-7) and 10(-6) M Bay k 8644 accelerated and broadened the calcium transients.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7675124     DOI: 10.1007/bf00170165

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  25 in total

1.  A multicenter, randomized, double-blind, placebo-controlled trial of pimobendan, a new cardiotonic and vasodilator agent, in patients with severe congestive heart failure.

Authors:  S D Katz; S H Kubo; M Jessup; S Brozena; J M Troha; J Wahl; J N Cohn; E H Sonnenblick; T H LeJemtel
Journal:  Am Heart J       Date:  1992-01       Impact factor: 4.749

2.  Contribution of cAMP-phosphodiesterase inhibition and sensitization of the contractile proteins for calcium to the inotropic effect of pimobendan in the failing human myocardium.

Authors:  M Böhm; I Morano; B Pieske; J C Rüegg; M Wankerl; R Zimmermann; E Erdmann
Journal:  Circ Res       Date:  1991-03       Impact factor: 17.367

3.  Influence of UDCG-115 on hemodynamics and myocardial energetics in patients with idiopathic dilated cardiomyopathy.

Authors:  G Hasenfuss; C Holubarsch; H W Heiss; H Just
Journal:  Am Heart J       Date:  1989-09       Impact factor: 4.749

4.  Different modes of Ca channel gating behaviour favoured by dihydropyridine Ca agonists and antagonists.

Authors:  P Hess; J B Lansman; R W Tsien
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

5.  The positive inotropic effect of pimobendan involves stereospecific increases in the calcium sensitivity of cardiac myofilaments.

Authors:  R J Solaro; K Fujino; N Sperelakis
Journal:  J Cardiovasc Pharmacol       Date:  1989       Impact factor: 3.105

6.  Post-extrasystolic potentiation and the force-frequency relationship: differential augmentation of myocardial contractility in working myocardium from patients with end-stage heart failure.

Authors:  P J Phillips; J K Gwathmey; M D Feldman; F J Schoen; W Grossman; J P Morgan
Journal:  J Mol Cell Cardiol       Date:  1990-01       Impact factor: 5.000

7.  Sensitization of dog and guinea pig heart myofilaments to Ca2+ activation and the inotropic effect of pimobendan: comparison with milrinone.

Authors:  K Fujino; N Sperelakis; R J Solaro
Journal:  Circ Res       Date:  1988-11       Impact factor: 17.367

8.  Effects of pimobendan, a novel inotropic agent, on intracellular calcium and tension in isolated ferret ventricular muscle.

Authors:  J A Lee; J C Ruegg; D G Allen
Journal:  Clin Sci (Lond)       Date:  1989-06       Impact factor: 6.124

9.  Vanadate and phosphate ions reduce tension and increase cross-bridge kinetics in chemically skinned heart muscle.

Authors:  J W Herzig; J W Peterson; J C Rüegg; R J Solaro
Journal:  Biochim Biophys Acta       Date:  1981-01-21

10.  Ca(2+)-dependent fluorescence transients and phosphate metabolism during low-flow ischemia in rat hearts.

Authors:  S A Camacho; V M Figueredo; R Brandes; M W Weiner
Journal:  Am J Physiol       Date:  1993-07
View more
  1 in total

1.  Reversal of phosphate induced decreases in force by the benzimidazole pyridazinone, UD-CG 212 CL, in myofilaments from human ventricle.

Authors:  L D Fraker; J Van Eyk; R J Solaro
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.